Aspartoacylase
From Proteopedia
(Difference between revisions)
Line 13: | Line 13: | ||
2GU2 is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2GU2 OCA]. | 2GU2 is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2GU2 OCA]. | ||
- | <scene name='49/498146/Cv/2'>Catalytic site</scene> of human aspartocyclase with aspartate analogue and Zn+2. | + | <scene name='49/498146/Cv/2'>Catalytic site</scene> of human aspartocyclase with <scene name='49/498146/Cv/3'>aspartate analogue and Zn+2</scene> ([[2o4h]]). |
</StructureSection> | </StructureSection> | ||
==GO Annotation== | ==GO Annotation== |
Revision as of 10:15, 15 November 2015
|
Contents |
GO Annotation
Database | ID | Symbol | Qualifier | GO Identifier | GO Term Name | Aspect | Evidence | Reference | With | Taxon | Date | Assigned By | Product Form ID |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Process | |||||||||||||
UniProtKB | Q9R1T5 | Aspa | GO:0008152 | metabolic process | P | IEA | InterPro2GO | InterPro:IPR007036 | 10116 | 20101127 | InterPro | ||
UniProtKB | Q9R1T5 | Aspa | GO:0022010 | central nervous system myelination | P | IEP | PMID:12524181 | 10116 | 20070129 | RGD | |||
UniProtKB | Q9R1T5 | Aspa | GO:0048714 | positive regulation of oligodendrocyte differentiation | P | IMP | PMID:16634055 | 10116 | 20070129 | RGD | |||
Function | |||||||||||||
UniProtKB | Q9R1T5 | Aspa | GO:0016787 | hydrolase activity | F | IEA | Swiss-Prot Keywords2GO | SP_KW:KW-0378 | 10116 | 20101127 | UniProtKB | ||
UniProtKB | Q9R1T5 | Aspa | GO:0016788 | hydrolase activity, acting on ester bonds | F | IEA | InterPro2GO | InterPro:IPR007036 | 10116 | 20101127 | InterPro | ||
UniProtKB | Q9R1T5 | Aspa | GO:0019807 | aspartoacylase activity | F | IEA | EC2GO | EC:3.5.1.15 | 10116 | 20100703 | UniProtKB | ||
UniProtKB | Q9R1T5 | Aspa | GO:0019807 | aspartoacylase activity | F | TAS | PMID:12524181 | 10116 | 20050217 | RGD | |||
UniProtKB | Q9R1T5 | Aspa | GO:0046872 | metal ion binding | F | IEA | Swiss-Prot Keywords2GO | SP_KW:KW-0479 | 10116 | 20101127 | UniProtKB | ||
Component | |||||||||||||
UniProtKB | Q9R1T5 | Aspa | GO:0005634 | nucleus | C | IDA | PMID:16935940 | 10116 | 20070129 | RGD | |||
UniProtKB | Q9R1T5 | Aspa | GO:0005634 | nucleus | C | IEA | Swiss-Prot Keywords2GO | SP_KW:KW-0539 | 10116 | 20101127 | UnitProtKB | ||
UniProtKB | Q9R1T5 | Aspa | GO:0005634 | nucleus | C | IEA | Subcellular Location2GO | SP_SL:SL-0191 | 10116 | 20101127 | UniProtKB | ||
UniProtKB | Q9R1T5 | Aspa | GO:0005737 | cytoplasm | C | IDA | PMID:16935940 | 10116 | 20070129 | RGD | |||
UniProtKB | Q9R1T5 | Aspa | GO:0005737 | cytoplasm | C | IEA | Swiss-Prot Keywords2GO | SP_KW:KW-0963 | 10116 | 20101127 | UniProtKB | ||
UniProtKB | Q9R1T5 | Aspa | GO:0005737 | cytoplasm | C | IEA | Subcellular Location2GO | SP_SL:SL-0086 | 10116 | 20101127 | UniProtKB |
3D structures of aspartoacylase
Updated on 15-November-2015
2gu2, 2q4z – AAC – rat
2i3c, 2q51, 2o53 – hAAC – human
2o4h – hAAC + intermediate analog
4mri, 4mxu, 4nfr, 4tnu - hAAC (mutant) + intermediate analog
3nfz – mAAC-2 (mutant) + acetyl-tyrosine – mouse
3nh4 – mAAC-2
3nh5 - mAAC-2 (mutant)
3nh8 - mAAC-2 (mutant) + acetyl-dichlorovinyl-cysteine
References
- ↑ http://www.uniprot.org/uniprot/Q9R1T5
- ↑ Bitto E, Bingman CA, Wesenberg GE, McCoy JG, Phillips GN Jr. Structure of aspartoacylase, the brain enzyme impaired in Canavan disease. Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):456-61. Epub 2006 Dec 28. PMID:17194761
- ↑ http://www.ebi.ac.uk/QuickGO/GProtein?ac=Q9R1T5
Additional Literature and Resources
- Bitto E, Bingman CA, Wesenberg GE, McCoy JG, Phillips GN Jr. Structure of aspartoacylase, the brain enzyme impaired in Canavan disease. Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):456-61. Epub 2006 Dec 28. PMID:17194761
- See: Canavan disease for Additional information on this disease.
- Created with the participation of Robert Abbott.
Categories: Topic Page | Aspartoacylase | Rattus norvegicus | Bingman, C A. | Bitto, E. | CESG, Center for Eukaryotic Structural Genomics. | Jr., G N.Phillips. | Wesenberg, G E. | Acy-2 | Acy2 rat | Aminoacylase-2 | Aspartoacylase family | Center for eukaryotic structural genomic | Cesg | Protein structure initiative | Psi | Structural genomic